Viewing Study NCT00003304


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-29 @ 11:18 AM
Study NCT ID: NCT00003304
Status: COMPLETED
Last Update Posted: 2012-03-06
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module